Vivo Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Vivo Capital, LLC

  • $683 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$19.08 - $36.14 $4.06 Million - $7.69 Million
-212,648 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$33.57 - $42.1 $1.35 Million - $1.7 Million
-40,294 Reduced 15.93%
212,648 $8.23 Million
Q2 2018

Aug 10, 2018
BUY
$20.06 - $44.95 $5.07 Million - $11.4 Million
252,942 New
252,942 $9.95 Million

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email